Skip to content

Clinical trials

Observational Respiratory Tract Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Observational Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20201
20212
20222
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status3
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Beijing Children's Hospital2
China-Japan Friendship Hospital1
Nanfang Hospital, Southern Medical University1
Sichuan Provincial People's Hospital1
Xiangya Hospital of Central South University1
Zhibin Xu1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases10
Neoplasms4
Bronchial Neoplasms3
Carcinoma, Bronchogenic3
Carcinoma, Non-Small-Cell Lung3
Lung Diseases3
Lung Neoplasms3
Neoplasms by Site3
Respiratory Tract Neoplasms3
Thoracic Neoplasms3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.